Literature DB >> 20735358

The chaperone proteins HSP70, HSP40/DnaJ and GRP78/BiP suppress misfolding and formation of β-sheet-containing aggregates by human amylin: a potential role for defective chaperone biology in Type 2 diabetes.

Vita Chien1, Jacqueline F Aitken, Shaoping Zhang, Christina M Buchanan, Anthony Hickey, Thomas Brittain, Garth J S Cooper, Kerry M Loomes.   

Abstract

Misfolding of the islet β-cell peptide hA (human amylin) into β-sheet-containing oligomers is linked to β-cell apoptosis and the pathogenesis of T2DM (Type 2 diabetes mellitus). In the present study, we have investigated the possible effects on hA misfolding of the chaperones HSP (heat-shock protein) 70, GRP78/BiP (glucose-regulated protein of 78 kDa/immunoglobulin heavy-chain-binding protein) and HSP40/DnaJ. We demonstrate that hA underwent spontaneous time-dependent β-sheet formation and aggregation by thioflavin-T fluorescence in solution, whereas rA (rat amylin) did not. HSP70, GRP78/BiP and HSP40/DnaJ each independently suppressed hA misfolding. Maximal molar protein/hA ratios at which chaperone activity was detected were 1:200 (HSP70, HSP40/DnaJ and GRP78/BiP). By contrast, none of the chaperones modified the secondary structure of rA. hA, but not rA, was co-precipitated independently with HSP70 and GRP78/BiP by anti-amylin antibodies. As these effects occur at molar ratios consistent with chaperone binding to relatively rare misfolded hA species, we conclude that HSP70 and GRP78/BiP can detect and bind misfolded hA oligomers, thereby effectively protecting hA against bulk misfolding and irreversible aggregation. Defective β-cell chaperone biology could contribute to hA misfolding and initiation of apoptosis in T2DM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20735358     DOI: 10.1042/BJ20100434

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  Physiologic Doses of Bilirubin Contribute to Tolerance of Islet Transplants by Suppressing the Innate Immune Response.

Authors:  Christopher A Adin; Zachary C VanGundy; Tracey L Papenfuss; Feng Xu; Mostafa Ghanem; Jonathan Lakey; Gregg A Hadley
Journal:  Cell Transplant       Date:  2016-07-07       Impact factor: 4.064

Review 2.  Impaired proteostasis: role in the pathogenesis of diabetes mellitus.

Authors:  Stéphane Jaisson; Philippe Gillery
Journal:  Diabetologia       Date:  2014-05-11       Impact factor: 10.122

3.  A two-site mechanism for the inhibition of IAPP amyloidogenesis by zinc.

Authors:  Samer Salamekh; Jeffrey R Brender; Suk-Joon Hyung; Ravi Prakash Reddy Nanga; Subramanian Vivekanandan; Brandon T Ruotolo; Ayyalusamy Ramamoorthy
Journal:  J Mol Biol       Date:  2011-05-17       Impact factor: 5.469

Review 4.  Neuroendocrine hormone amylin in diabetes.

Authors:  Xiao-Xi Zhang; Yan-Hong Pan; Yan-Mei Huang; Hai-Lu Zhao
Journal:  World J Diabetes       Date:  2016-05-10

5.  Toxicant-mediated redox control of proteostasis in neurodegeneration.

Authors:  Stefanos Aivazidis; Colin C Anderson; James R Roede
Journal:  Curr Opin Toxicol       Date:  2018-12-28

6.  HSPA5 forms specific complexes with copper.

Authors:  Yongchang Qian; Bingchao Meng; Xuchu Zhang; Ying Zheng; Robert Taylor; Evelyn Tiffany-Castiglioni
Journal:  Neurochem Res       Date:  2012-11-17       Impact factor: 3.996

Review 7.  Modulation of Amyloid States by Molecular Chaperones.

Authors:  Anne Wentink; Carmen Nussbaum-Krammer; Bernd Bukau
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

8.  Association between promoter polymorphisms of the GRP78 gene and risk of type 2 diabetes in a Chinese Han population.

Authors:  Shengyuan Liu; Keshen Li; Tao Li; Xingdong Xiong; Songpo Yao; Zhongwei Chen; Changyi Wang; Bin Zhao
Journal:  DNA Cell Biol       Date:  2013-02-12       Impact factor: 3.311

9.  Hsp70 Inhibits Aggregation of IAPP by Binding to the Heterogeneous Prenucleation Oligomers.

Authors:  Neeraja Chilukoti; Timir Baran Sil; Bankanidhi Sahoo; S Deepa; Sreelakshmi Cherakara; Mithun Maddheshiya; Kanchan Garai
Journal:  Biophys J       Date:  2021-01-06       Impact factor: 4.033

10.  KU-32, a novel drug for diabetic neuropathy, is safe for human islets and improves in vitro insulin secretion and viability.

Authors:  Kevin Farmer; S Janette Williams; Lesya Novikova; Karthik Ramachandran; Sonia Rawal; Brian S J Blagg; Rick Dobrowsky; Lisa Stehno-Bittel
Journal:  Exp Diabetes Res       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.